Colistin conditioning surfaces combined with antimicrobial treatment to prevent ventilator-associated infections

References

• Adair CG, Gorman SP, Feron BM, Byers LM, Jones DS, Goldsmith CE, Moore JE, Kerr JR, Curran MD, Hogg G, et al. 1999. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med. 25:1072–1076. doi:10.1007/s001340051014
   PubMed Web of Science ®Google Scholar
• Berra L, Coppadoro A, Bittner EA, Kolobow T, Laquerriere P, Pohlmann JR, Bramati S, Moss J, Pesenti A. 2012. A clinical assessment of the Mucus Shaver. Crit Care Med. 40:119–124. doi:10.1097/CCM.0b013e31822e9fe3
   PubMed Web of Science ®Google Scholar
• Biel MA, Sievert C, Usacheva M, Teichert M, Wedell E, Loebel N, Rose A, Zimmermann R. 2011. Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy. Lasers Surg Med. 43:586–590. doi:10.1002/lsm.21103
   PubMed Web of Science ®Google Scholar
• Blair JM, Richmond GE, Piddock LJ. 2014. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 9:1165–1177. doi:10.2217/fmb.14.66
   PubMed Web of Science ®Google Scholar
• Cassir N, Rolain J-M, Brouqui P. 2014. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol. 5:551. doi:10.3389/fmicb.2014.00551
   PubMed Web of Science ®Google Scholar
• Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J. 2005. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother. 56:331–336. doi:10.1093/jac/dki217
   PubMed Web of Science ®Google Scholar
• CLSI and CaLS I. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically.
   Google Scholar
• Das T, Kutty SK, Tavallaie R, Ibugo AI, Panchompoo J, Sehar S, et al. 2015. Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation. Sci Reports. 5:1–9.
   Web of Science ®Google Scholar
• de Bentzmann S, Plésiat P. 2011. The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol. 13:1655–1665. doi:10.1111/j.1462-2920.2011.02469.x
   PubMedGoogle Scholar
• Diaconu O, Siriopol I, Poloșanu LI, Grigoraș I. 2018. Endotracheal tube biofilm and its impact on the pathogenesis of ventilator-associated pneumonia. J Crit Care Med. e-Pub Ahead of Print. doi:10.2478/jccm-2018-0011
   Google Scholar
• El Solh AA, Alhajhusain A. 2009. Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother. 64:229–238. doi:10.1093/jac/dkp201
   PubMed Web of Science ®Google Scholar
• Falagas ME, Kasiakou SK, Saravolatz LD. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 40:1333–1341. doi:10.1086/429323
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rafailidis PI, Matthaiou DK. 2010. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat. 13:132–138. doi:10.1016/j.drup.2010.05.002
   PubMed Web of Science ®Google Scholar
• Flemming H-C, Wingender J. 2010. The biofilm matrix. Nat Rev Microbiol. 8:623–633. doi:10.1038/nrmicro2415
   PubMed Web of Science ®Google Scholar
• Gilbert P, Das J, Foley I. 1997. Biofilm susceptibility to antimicrobials. Adv Dent Res. 11:160–167. doi:10.1177/08959374970110010701
   PubMedGoogle Scholar
• Gillis RJ, Iglewski BH. 2004. Azithromycin retards Pseudomonas aeruginosa biofilm formation. J Clin Microbiol. 42:5842–5845. doi:10.1128/JCM.42.12.5842-5845.2004
   PubMed Web of Science ®Google Scholar
• Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE. 2012. Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens. Expert Rev Respir Med. 6:533–555. doi:10.1586/ers.12.45
   PubMed Web of Science ®Google Scholar
• Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE. 2013. Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Curr Opin Infect Dis. 26:140–150. doi:10.1097/QCO.0b013e32835ebbd0
   PubMed Web of Science ®Google Scholar
• Hauser AR. 2011. Pseudomonas aeruginosa: so many virulence factors, so little time. Crit Care Med. e-pub ahead of print. doi:10.1097/CCM.0b013e318221742d
   PubMedGoogle Scholar
• Jorge P, Alves D, Pereira MO. 2019. Catalysing the way towards antimicrobial effectiveness: a systematic analysis and a new online resource for antimicrobial–enzyme combinations against Pseudomonas aeruginosa and Staphylococcus aureus. Int J Antimicrob Agents. e-pub ahead of print, doi:10.1016/j.ijantimicag.2019.01.001
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratalà J, et al. 2016. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 63:e61–e111. doi:10.1093/cid/ciw353
   PubMed Web of Science ®Google Scholar
• Katsikogianni M, Missirlis YF. 2004. Concise review of mechanisms of bacterial adhesion to biomaterials and of techniques used in estimating bacteria-material interactions. Eur Cell Mater. 8:37–57. doi:10.22203/ecm.v008a05
   PubMedGoogle Scholar
• Ko E, Yang K, Shin J, Cho S-W. 2013. Polydopamine-assisted osteoinductive peptide immobilization of polymer scaffolds for enhanced bone regeneration by human adipose-derived stem cells. Biomacromolecules. 14:3202–3213. doi:10.1021/bm4008343
   PubMed Web of Science ®Google Scholar
• Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, NASCENT Investigation Group, et al. 2008. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA. 300:805–813. doi:10.1001/jama.300.7.805
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Balkis M, Chandra J, Mukherjee PK, Ghannoum MA. 2003. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol. 41:506–508. doi:10.1128/JCM.41.1.506-508.2003
   PubMed Web of Science ®Google Scholar
• Liu W, Zuo Z, Ma R, Zhang X. 2013. Effect of mechanical cleaning of endotracheal tubes with sterile urethral catheters to reduce biofilm formation in ventilator patients. Pediatr Crit Care Med. 14:e338–e343.
   PubMed Web of Science ®Google Scholar
• Machado I, Graça J, Sousa AM, Lopes SP, Grac J. 2011. Effect of antimicrobial residues on early adhesion and biofilm formation by wild-type and benzalkonium chloride-adapted Pseudomonas aeruginosa. Biofouling. 27:1151–1141. doi:10.1080/08927014.2011.636148
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, Torres A, Rinaudo M, Terraneo S, de Rosa F, Ramirez P, Diaz E, Fernández-Barat L, Li bassi GL, Ferrer M, et al. 2015. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organi. J Infect. 70:213–222. doi:10.1016/j.jinf.2014.10.004
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Falagas ME. 2008. Colistin and Polymyxin B in critical care. Crit Care Clin. 24:377–391. doi:10.1016/j.ccc.2007.12.003
   PubMed Web of Science ®Google Scholar
• Minardi D, Ghiselli R, Cirioni O, Giacometti A, Kamysz W, Orlando F, Silvestri C, Parri G, Kamysz E, Scalise G, et al. 2007. The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model. Peptides. 28:2293–2298. doi:10.1016/j.peptides.2007.10.001
   PubMed Web of Science ®Google Scholar
• Monteiro R, Silva E, Grainha T, Alves D, Pereira MO, Sousa AM. 2020. Fostering innovation in the treatment of chronic polymicrobial cystic fibrosis-associated infections exploring aspartic acid and succinic acid as ciprofloxacin adjuvants. Front Cell Infect Microbiol. 10:441. e-pub ahead of print, doi:10.3389/fcimb.2020.00441
   PubMed Web of Science ®Google Scholar
• Moradali MF, Ghods S, Rehm BHA. 2017. Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell. Infect Microbiol. e-pub ahead of print, doi:10.3389/fcimb.2017.00039
   Google Scholar
• Olson ME, Harmon BG, Kollef MH. 2002. Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest. 121:863–870. doi:10.1378/chest.121.3.863
   PubMed Web of Science ®Google Scholar
• Pang Z, Raudonis R, Glick B, Lin T, Cheng Z. 2019. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 37:177–192. doi:10.1016/j.biotechadv.2018.11.013
   PubMed Web of Science ®Google Scholar
• Pinciroli R, Mietto C, Berra L. 2013. Respiratory therapy device modifications to prevent ventilator-associated pneumonia. Curr Opin Infect Dis. 26:175–183. doi:10.1097/QCO.0b013e32835d3349
   PubMed Web of Science ®Google Scholar
• Pires D, Sillankorva S, Faustino A, Azeredo J. 2011. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms. Res Microbiol. 162:798–806. doi:10.1016/j.resmic.2011.06.010
   PubMed Web of Science ®Google Scholar
• Prakash B, Veeregowda BM, Krishnappa G. 2003. Biofilms: a survival strategy of bacteria. Curr Sci. 85.
   Web of Science ®Google Scholar
• Prat C, Lacoma A. 2016. Bacteria in the respiratory tract-how to treat? Or do not treat? Int J Infect Dis. 51:113–122. doi:10.1016/j.ijid.2016.09.005
   PubMed Web of Science ®Google Scholar
• Ramsey MM, Whiteley M. 2004. Pseudomonas aeruginosa attachment and biofilm development in dynamic environments. Mol Microbiol. 53:1075–1087. doi:10.1111/j.1365-2958.2004.04181.x
   PubMed Web of Science ®Google Scholar
• Raymond B. 2019. Five rules for resistance management in the antibiotic apocalypse, a road map for integrated microbial management. Evol Appl. 12:1079–1091. doi:10.1111/eva.12808
   PubMed Web of Science ®Google Scholar
• Rello J, Ramirez Estrada S, Borgatta B. 2016. Pseudomonas aeruginosa ventilator-associated pneumonia management. Infect Drug Resist. 9:7–18. doi:10.2147/IDR.S50669
   PubMed Web of Science ®Google Scholar
• Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. 1991. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods. 142:257–265. doi:10.1016/0022-1759(91)90114-u
   PubMed Web of Science ®Google Scholar
• Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. 2000. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 40:175–179. doi:10.1016/s0167-7012(00)00122-6
   PubMed Web of Science ®Google Scholar
• Stevens MG, Olsen SC. 1993. Comparative analysis of using MTT and XTT in colorimetric assays for quantitating bovine neutrophil bactericidal activity. J Immunol Methods. 157:225–231. doi:10.1016/0022-1759(93)90091-k
   PubMed Web of Science ®Google Scholar
• Van Oss CJ, Giese RF. 1995. The hydrophilicity and hydrophobicity of clay minerals. Clays Clay Miner. e-pub ahead of print, doi:10.1346/CCMN.1995.0430411
   Web of Science ®Google Scholar
• van Oss CJ. 1997. Hydrophobicity and hydrophilicity of biosurfaces. Curr Opin Colloid Interface Sci. 2:503–512. doi:10.1016/S1359-0294(97)80099-4
   Web of Science ®Google Scholar
• Vandecandelaere I, Van Acker H, Coenye T. 2016. A microplate-based system as in vitro model of biofilm growth and quantification. Methods Mol Biol. 1333:53–66. doi:10.1007/978-1-4939-2854-5_5
   PubMedGoogle Scholar
• Wood TK, Knabel SJ, Kwan BW. 2013. Bacterial persister cell formation and dormancy. Appl Environ Microbiol. 79:7116–7121. doi:10.1128/AEM.02636-13
   PubMed Web of Science ®Google Scholar
• Worthington RJ, Melander C. 2013. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol. e-pub ahead of print, doi:10.1016/j.tibtech.2012.12.006
   PubMed Web of Science ®Google Scholar
• Wu D, Wu C, Zhang S, Zhong Y. 2019. Risk factors of ventilator-associated pneumonia in critically III patients. Front Pharmacol. 10:1–7.
   PubMed Web of Science ®Google Scholar
• Yahav D, Farbman L, Leibovici L, Paul M. 2012. Colistin: new lessons on an old antibiotic. Clin Microbiol Infect. 18:18–29. doi:10.1111/j.1469-0691.2011.03734.x
   PubMed Web of Science ®Google Scholar
• Yu Z, Qin W, Lin J, Fang S, Qiu J. 2015. Antibacterial mechanisms of polymyxin and bacterial resistance. Biomed Res Int. 2015:1–11.
   Web of Science ®Google Scholar